{"id":"https://openalex.org/W2002108880","doi":"https://doi.org/10.1097/00002030-199504000-00006","title":"Development of HIV-1 resistance to (\u2212)2\u2032-deoxy-3\u2032-thiacytidine in patients with AIDS or advanced AIDS-related complex","display_name":"Development of HIV-1 resistance to (\u2212)2\u2032-deoxy-3\u2032-thiacytidine in patients with AIDS or advanced AIDS-related complex","publication_year":1995,"publication_date":"1995-04-01","ids":{"openalex":"https://openalex.org/W2002108880","doi":"https://doi.org/10.1097/00002030-199504000-00006","mag":"2002108880","pmid":"https://pubmed.ncbi.nlm.nih.gov/7540846"},"language":"en","primary_location":{"id":"doi:10.1097/00002030-199504000-00006","doi":"https://doi.org/10.1097/00002030-199504000-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-199504000-00006","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029881635","display_name":"Mark A. Wainberg","orcid":"https://orcid.org/0000-0002-0272-1317","observed_orcids":["https://orcid.org/0000-0002-0272-1317"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Mark A. Wainberg","raw_affiliation_strings":["Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","Date of receipt: 24 October 1994","From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","accepted: 2 February 1995","revised: 30 January 1995"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","institution_ids":[]},{"raw_affiliation_string":"Date of receipt: 24 October 1994","institution_ids":[]},{"raw_affiliation_string":"From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I141945490","https://openalex.org/I2801362399","https://openalex.org/I2801824472","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"revised: 30 January 1995","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108089009","display_name":"Horacio Salom\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Horacio Salomon","raw_affiliation_strings":["Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","Date of receipt: 24 October 1994","From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","accepted: 2 February 1995","revised: 30 January 1995"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","institution_ids":[]},{"raw_affiliation_string":"Date of receipt: 24 October 1994","institution_ids":[]},{"raw_affiliation_string":"From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I141945490","https://openalex.org/I2801362399","https://openalex.org/I2801824472","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"revised: 30 January 1995","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047564425","display_name":"Zhengxian Gu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Zhengxian Gu","raw_affiliation_strings":["Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","Date of receipt: 24 October 1994","From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","accepted: 2 February 1995","revised: 30 January 1995"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","institution_ids":[]},{"raw_affiliation_string":"Date of receipt: 24 October 1994","institution_ids":[]},{"raw_affiliation_string":"From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I141945490","https://openalex.org/I2801362399","https://openalex.org/I2801824472","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"revised: 30 January 1995","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074441717","display_name":"Julio S. G. Montaner","orcid":"https://orcid.org/0000-0002-6201-9829","observed_orcids":["https://orcid.org/0000-0002-6201-9829"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Julio S.G. Montaner","raw_affiliation_strings":["Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","Date of receipt: 24 October 1994","From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","accepted: 2 February 1995","revised: 30 January 1995"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","institution_ids":[]},{"raw_affiliation_string":"Date of receipt: 24 October 1994","institution_ids":[]},{"raw_affiliation_string":"From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I141945490","https://openalex.org/I2801362399","https://openalex.org/I2801824472","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"revised: 30 January 1995","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080862046","display_name":"Timothy Patrick Cooley","orcid":"https://orcid.org/0000-0002-3373-1569","observed_orcids":["https://orcid.org/0000-0002-3373-1569"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Timothy P. Cooley","raw_affiliation_strings":["Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","Date of receipt: 24 October 1994","From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","accepted: 2 February 1995","revised: 30 January 1995"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","institution_ids":[]},{"raw_affiliation_string":"Date of receipt: 24 October 1994","institution_ids":[]},{"raw_affiliation_string":"From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I141945490","https://openalex.org/I2801362399","https://openalex.org/I2801824472","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"revised: 30 January 1995","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113549073","display_name":"Ronald P. McCaffrey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Ronald McCaffrey","raw_affiliation_strings":["Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","Date of receipt: 24 October 1994","From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","accepted: 2 February 1995","revised: 30 January 1995"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","institution_ids":[]},{"raw_affiliation_string":"Date of receipt: 24 October 1994","institution_ids":[]},{"raw_affiliation_string":"From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I141945490","https://openalex.org/I2801362399","https://openalex.org/I2801824472","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"revised: 30 January 1995","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113760073","display_name":"John R. Ruedy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"John Ruedy","raw_affiliation_strings":["Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","Date of receipt: 24 October 1994","From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","accepted: 2 February 1995","revised: 30 January 1995"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","institution_ids":[]},{"raw_affiliation_string":"Date of receipt: 24 October 1994","institution_ids":[]},{"raw_affiliation_string":"From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I141945490","https://openalex.org/I2801362399","https://openalex.org/I2801824472","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"revised: 30 January 1995","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001645229","display_name":"Hilary M. Hirst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Hilary M. Hirst","raw_affiliation_strings":["Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","Date of receipt: 24 October 1994","From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","accepted: 2 February 1995","revised: 30 January 1995"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","institution_ids":[]},{"raw_affiliation_string":"Date of receipt: 24 October 1994","institution_ids":[]},{"raw_affiliation_string":"From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I141945490","https://openalex.org/I2801362399","https://openalex.org/I2801824472","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"revised: 30 January 1995","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112178377","display_name":"Nick Cammack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Nick Cammack","raw_affiliation_strings":["Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","Date of receipt: 24 October 1994","From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","accepted: 2 February 1995","revised: 30 January 1995"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","institution_ids":[]},{"raw_affiliation_string":"Date of receipt: 24 October 1994","institution_ids":[]},{"raw_affiliation_string":"From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I141945490","https://openalex.org/I2801362399","https://openalex.org/I2801824472","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"revised: 30 January 1995","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110146237","display_name":"Janet M. Cameron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Janet Cameron","raw_affiliation_strings":["Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","Date of receipt: 24 October 1994","From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","accepted: 2 February 1995","revised: 30 January 1995"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","institution_ids":[]},{"raw_affiliation_string":"Date of receipt: 24 October 1994","institution_ids":[]},{"raw_affiliation_string":"From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I141945490","https://openalex.org/I2801362399","https://openalex.org/I2801824472","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"revised: 30 January 1995","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Wendy Nicholson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]},{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Wendy Nicholson","raw_affiliation_strings":["Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","Date of receipt: 24 October 1994","From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","accepted: 2 February 1995","revised: 30 January 1995"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Date of receipt: 24 October 1994; revised: 30 January 1995; accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"Sponsorship: Supported by grants from Health Canada and by Glaxo, Inc","institution_ids":[]},{"raw_affiliation_string":"Date of receipt: 24 October 1994","institution_ids":[]},{"raw_affiliation_string":"From the McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, the *AIDS Research Program, St Paul's Hospital/University of British Columbia, Vancouver, British Columbia, Canada, the \u2020Sections of Hematology and Oncology, and Clinical AIDS Program, Department of Medicine, Boston City Hospital and Boston University School of Medicine, Boston, Massachusetts, \u2021Glaxo Research Institute, Research Triangle Park, North Carolina, USA and \u00a7Glaxo Group Research, Greenford, UK","institution_ids":["https://openalex.org/I111088046","https://openalex.org/I141945490","https://openalex.org/I2801362399","https://openalex.org/I2801824472","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Requests for reprints to: Dr Mark A. Wainberg, McGill University AIDS Centre, Jewish General Hospital, 3755 C\u00f4te-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"raw_affiliation_string":"accepted: 2 February 1995","institution_ids":[]},{"raw_affiliation_string":"revised: 30 January 1995","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":11.1998,"has_fulltext":false,"cited_by_count":119,"citation_normalized_percentile":{"value":0.98751608,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"9","issue":"4","first_page":"351","last_page":"357"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.9070000052452087},{"id":"https://openalex.org/keywords/zalcitabine","display_name":"zalcitabine","score":0.875},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8460000157356262},{"id":"https://openalex.org/keywords/reverse-transcriptase","display_name":"reverse transcriptase","score":0.4790000021457672},{"id":"https://openalex.org/keywords/emergence-of-resistance","display_name":"emergence of resistance","score":0.3970000147819519},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5120000243186951},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.6389999985694885},{"id":"https://openalex.org/keywords/aids-related-complex","display_name":"AIDS-related complex","score":0.7400000095367432},{"id":"https://openalex.org/keywords/viral-load","display_name":"viral load","score":0.3230000138282776}],"concepts":[{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.8340727090835571},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.6486758589744568},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5663478374481201},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5436519980430603},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5311962962150574},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.5290716290473938},{"id":"https://openalex.org/C2777563447","wikidata":"https://www.wikidata.org/wiki/Q7243397","display_name":"Primer (cosmetics)","level":2,"score":0.4532516896724701},{"id":"https://openalex.org/C2776955114","wikidata":"https://www.wikidata.org/wiki/Q172563","display_name":"Umbilical cord","level":2,"score":0.44864895939826965},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4380946457386017},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.4324544668197632},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4108860194683075},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3902361989021301},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38149788975715637},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.37441200017929077},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13283595442771912},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11247539520263672},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.10135170817375183},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000386","descriptor_name":"AIDS-Related Complex","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000386","descriptor_name":"AIDS-Related Complex","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D001483","descriptor_name":"Base Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004352","descriptor_name":"Drug Resistance, Microbial","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011533","descriptor_name":"Proviruses","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011533","descriptor_name":"Proviruses","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D016047","descriptor_name":"Zalcitabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016047","descriptor_name":"Zalcitabine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D016047","descriptor_name":"Zalcitabine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017931","descriptor_name":"DNA Primers","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054303","descriptor_name":"HIV Reverse Transcriptase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/00002030-199504000-00006","doi":"https://doi.org/10.1097/00002030-199504000-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-199504000-00006","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"doi:10.1097/00002030-199509040-00006","doi":"https://doi.org/10.1097/00002030-199509040-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-199509040-00006","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:7540846","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7540846","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8399999737739563,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2053135778","https://openalex.org/W2416424586","https://openalex.org/W2057227263","https://openalex.org/W4251656648","https://openalex.org/W2026323517","https://openalex.org/W2017854107","https://openalex.org/W2154470435","https://openalex.org/W2097059709","https://openalex.org/W2941961467","https://openalex.org/W2140707155"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"determine":[2],"the":[3,17,112,213,273],"rate":[4],"of":[5,7,19,23,66,104,111,142,165,177,182,186,189,215,249,260,268,275],"development":[6,214,259],"in":[8,50,55,102,162,204,245,283],"vitro":[9,240],"HIV":[10,86,118,155],"resistance":[11,119,159,179,241,261],"to":[12,21,62,71,120,223,242,262,280],"(-)2'-deoxy-3'-thiacytidine":[13],"(3TC)":[14],"and":[15,28,64,76,173,211,272,287],"relate":[16],"effect":[18,65],"dose":[20],"emergence":[22],"resistance.":[24,218],"METHODS:":[25],"HIV-infected":[26],"men":[27],"non-pregnant":[29],"women,":[30],"aged":[31],">":[32],"or":[33,42],"=":[34,43],"18":[35],"years,":[36],"with":[37,69,117,255,266,278],"a":[38,51,221,232,246],"CD4":[39],"count":[40],"<":[41],"300":[44],"x":[45],"10(6)/l":[46],"cells":[47,94,98,140],"were":[48,58,79,99,169,208],"followed":[49,170],"Phase":[52],"I/II":[53],"study,":[54],"which":[56],"they":[57],"evaluated":[59],"for":[60,84],"tolerance":[61],"3TC":[63,178,197,217,243,263],"this":[67,256],"agent":[68],"regard":[70,279],"viral":[72,270],"susceptibility.":[73],"Peripheral":[74],"blood":[75,92,138],"plasma":[77,286],"samples":[78],"collected":[80],"at":[81,195,201,235],"regular":[82],"intervals":[83],"analysis.":[85],"was":[87,122,160,264],"isolated":[88],"using":[89,128],"umbilical":[90],"cord":[91],"mononuclear":[93,139],"as":[95],"targets.":[96],"These":[97],"also":[100],"used":[101],"determinations":[103],"median":[105],"inhibitory":[106],"drug":[107],"concentration.":[108],"Specific":[109],"amplification":[110],"184":[113,203],"mutation":[114],"site,":[115],"associated":[116,209,265],"3TC,":[121],"performed":[123],"by":[124,231],"polymerase":[125],"chain":[126],"reaction,":[127],"specific":[129],"primer":[130],"pairs,":[131],"on":[132,146],"DNA":[133,147],"harvested":[134],"from":[135,153],"infected":[136],"peripheral":[137],"(PBMC)":[141],"donors":[143],"or,":[144],"alternatively,":[145],"that":[148],"had":[149],"been":[150],"reverse":[151,206],"transcribed":[152],"plasma-associated":[154],"RNA.":[156],"RESULTS:":[157],"Phenotypic":[158],"detected":[161],"approximately":[163],"one-third":[164],"individuals":[166],"studied,":[167],"who":[168,251],"between":[171],"8":[172],"56":[174],"weeks.":[175],"Development":[176],"occurred":[180],"independently":[181],"dose,":[183],"although":[184],"time":[185],"first":[187],"appearance":[188,267],"resistant":[190],"HIV-1":[191,205],"variants":[192],"appeared":[193,226],"reduced":[194],"high":[196,247],"doses.":[198],"Amino-acid":[199],"changes":[200],"codon":[202,236,281],"transcriptase":[207],"with,":[210],"preceded,":[212],"phenotypic":[216],"Most":[219],"commonly,":[220],"Met":[222],"Ile":[224],"substitution":[225,234],"transiently":[227],"before":[228],"being":[229],"superceded":[230],"Val":[233],"184.":[237],"CONCLUSIONS:":[238],"In":[239],"developed":[244],"proportion":[248],"subjects":[250],"received":[252],"prolonged":[253],"monotherapy":[254],"drug.":[257],"The":[258],"mutated":[269],"forms":[271],"disappearance":[274],"wild-type":[276],"virus,":[277],"184,":[282],"both":[284],"patient":[285],"PBMC.":[288]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}